𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targeting the growth factors and angiogenesis pathways: Small molecules in solid tumors

✍ Scribed by David Berz; Harold Wanebo

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
316 KB
Volume
103
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Total cyclooxygenase-2 mRNA levels corre
Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients
✍ Ang Yuan; Chong-Jen Yu; Chia-Tung Shun; Kwen-Tay Luh; Sow-Hsong Kuo; Yung-Chie L 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 714 KB

## Abstract Interaction between cancer cells and adjacent stromal cells is important to promote tumor development. Our aim was to study total COX‐2 mRNA expression in both cancer cells and surrounding stromal cells and its association with angiogenic factor VEGF mRNA expression, tumor angiogenesis

Ascochlorin inhibits growth factor-induc
Ascochlorin inhibits growth factor-induced HIF-1α activation and tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K signaling pathway in human cervical carcinoma cells
✍ Ji-Hak Jeong; Yun-Jeong Jeong; Hyun-Ji Cho; Jae-Moon Shin; Jeong-Han Kang; Kwan- 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 582 KB

## Abstract Ascochlorin, a non‐toxic prenylphenol compound derived from the fungus __Ascochyta viciae__, has been shown recently to have anti‐cancer effects on various human cancer cells. However, the precise molecular mechanism of this anti‐cancer activity remains to be elucidated. Here, we invest

Targeting the IGF-1R using picropodophyl
Targeting the IGF-1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: Beneficial effects on tumor growth, angiogenesis, bone disease and survival
✍ Eline Menu; Helena Jernberg-Wiklund; Hendrik De Raeve; Evy De Leenheer; Les Coul 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 267 KB 👁 1 views

## Abstract During the last decade, a central role for insulin‐like growth factor 1 (IGF‐1) in the pathophysiology of multiple myeloma (MM) has been well established. IGF‐I provided by the tumor–microenvironment interaction may directly and indirectly facilitate the migration, survival and expansio

Bombesin/gastrin-releasing peptide antag
Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma
✍ Miklós Koppán; Gábor Halmos; José M. Arencibia; Najib Lamharzi; Andrew V. Schall 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

## BACKGROUND. Antagonists of bombesin/gastrin-releasing peptide (BN/GRP) have been developed to block the autocrine stimulatory effect of BN/GRP on tumors such as small cell lung carcinoma (SCLC). Although several studies have addressed the intracellular events that follow the formation of the re

The role of Fas ligand and transforming
The role of Fas ligand and transforming growth factor β in tumor progression : Molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy
✍ Ryungsa Kim; Manabu Emi; Kazuaki Tanabe; Yoko Uchida; Tetsuya Toge 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

## Abstract Despite the fact that expression of Fas ligand (FasL) in cytotoxic T lymphocytes (CTLs) and in natural killer (NK) cells plays an important role in Fas‐mediated tumor killing, During tumor progression FasL‐expressing tumor cells are involved in __counterattacking__ to kill tumor‐infiltr